Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.27 – $0.74
8% from low
Exchange
OTC Link
CS
ELITE PHARMS INC
No one on the platform currently holds ELTP.
No tracked institution reports a position in ELTP as of their last filing.
No one on the platform has traded ELTP yet.
$ELTP This stock was my first big winner and will always hold a special place in my heart 🥲 Come check out $PYNKF if you want another potential OTC runner. This company is still under the radar. They recently received FDA approval for their breast cancer identification device Claire and the entire trade thesis was hinging on commercialization. Yesterday they released news it’s being adopted in hospitals. 
View on StockTwits ↗$ELTP $DJT $TSLA $SPCX I wish Trump supports would read about how Trump is hurting everyone but himself and big Business . MAGA and the Left are more allike they then believe. Crony capitalism is Socialism without helping the poor or worker. I'm glad I own all the companies Trump and GOP are in bed with. This regime could be the biggest socialist government I have ever seen. Talk about Seizing the mean of production. Here Comes the Big Block Buys. This is being acquired slowly but surely. I think is a foreign company, so they don't have to pay tariffs. Elite Does a lot of Business in Israel. Nasrat has great connection all over the Middle East. Notice how quiet they all were about SequestOx??? That Is Always a Good Thing. FUN how much Trump is helping Elite...........
View on StockTwits ↗$ELTP $PFE $GME $META GREAT Call today. They Mentioned Trump ( in a good way ) One of the most talked-about rumors circulating is a potential share buyback program. If this comes to fruition, it would be a powerful signal of confidence from the company’s leadership, aiming to increase shareholder value by reducing outstanding shares and demonstrating belief in the company’s future prospects. Interestingly, for the first time ever, there was no mention of SequestOx during the call. Historically, SequestOx has been a frequent topic, so its absence is notable. In the world of corporate communications, silence on a previously prominent subject often suggests positive developments—nine times out of ten, it means there’s good news brewing behind the scenes. ELTP stock is now in play after this call. ( Roaring Kitty ? )
View on StockTwits ↗$ELTP worth the wait as things are in the works, then the sparks fly...... just patience is needed.. will be very rewarded... they have produced on what they say, just takes time unfortunately
View on StockTwits ↗$ELTP does nasdaq uplisting take place with a reverse split? I'm asking for anybody in the know because I think they have to be at least over a dollar to list
View on StockTwits ↗$ELTP $PFE $BAC $SPCX Call Conference was Great. Up-listing and Partnership confirmed and in the works. Thank God. Watch the Big Share buyback now through next year. Should drive it to 1.20 range.
View on StockTwits ↗$ELTP $DJT $GME Foreign Entity Buying us? Do you hear the good news about the Trump Tariffs for us? Watch the buying now.
View on StockTwits ↗$ELTP $GME $WEN $DJT Roaring Kitty is on the call, I heard a meow in the background !! (ELTP) is generating positive momentum, largely driven by its innovative product SequestOx™, which is currently FDA pending. SequestOx is an investigational immediate-release oxycodone combined with sequestered naltrexone, designed as an abuse-deterrent opioid product. This novel formulation aims to address the critical issue of opioid abuse while providing effective pain management. The FDA approval of SequestOx will be a significant milestone, positioning it as a potential game changer in the pharmaceutical market. Its unique abuse-deterrent properties could set a new standard for opioid medications, offering both safety and efficacy. I SequestOx is a promising advancement in opioid therapy, and its pending FDA status adds substantial value to Elite Pharmaceuticals. If approved, SequestOx will revolutionize pain management and abuse prevention. We Will Run Past .40 after the good news.
View on StockTwits ↗$ELTP I started buying this in 2020 and sold it for $0.50. I almost FOMO’d into this yesterday before earnings. The one thing that stopped is the fact that this company traded at or below earnings for YEARS. At this rate that would make this company a $0.10-$0.15 stock.
View on StockTwits ↗$ELTP down 110k in this. Going to be holding for the next 30 years to get even
View on StockTwits ↗$ELTP - picked up a few more but hate to see this drop....let's goooo!!
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ELTPElite Pharmaceuticals, Inc. | $0.32 | -12.13% | $339M | — |
| ABSCFAB Science S.A. | $1.12 | +0.00% | $82M | — |
| AGYTFAllergy Therapeutics plc | $0.15 | +0.00% | $756M | — |
| BOIRFBoiron S.A. | $31.50 | +0.00% | $547M | — |
| BPMUFBasilea Pharmaceutica AG | $65.50 | +0.00% | $811M | — |
| FOGCFAvisa Diagnostics Inc. | $0.00 | +0.00% | $97176 | — |
| GLASFGlass House Brands Inc. | $10.79 | -8.64% | $852M | — |
Source: Financial Modeling Prep · peers by sector/industry